Liam Moran

Publications by Year

Research Areas

Sphingolipid Metabolism and Signaling, Multiple Sclerosis Research Studies, Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism, Lipid Membrane Structure and Behavior

Most-Cited Works

• → Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)(2010)110 cited
• → Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders(2009)74 cited
• → Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate(2010)18 cited
• → Examination of the Utility of the High Throughput In Vitro Metabolic Stability Assay to Estimate In Vivo Clearance in the Mouse(2009)10 cited
• The impact of chitosan acetylation pattern on inflammation and toxicity(2018)